HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter A Calabresi Selected Research

Retrograde Degeneration

6/2017Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series.
2/2012Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.
2/2011Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter A Calabresi Research Topics

Disease

123Multiple Sclerosis
11/2022 - 06/2004
33Optic Neuritis (Retrobulbar Neuritis)
02/2022 - 02/2006
33Ganglion Cysts (Ganglion)
01/2022 - 11/2009
21Relapsing-Remitting Multiple Sclerosis
12/2021 - 04/2002
19Atrophy
11/2022 - 05/2010
15Inflammation (Inflammations)
10/2022 - 06/2005
14Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 04/2005
10Demyelinating Diseases (Demyelinating Disease)
10/2020 - 10/2005
8Disease Progression
11/2022 - 08/2007
7Neuromyelitis Optica (Devic's Disease)
01/2022 - 02/2012
7Autoimmune Diseases (Autoimmune Disease)
01/2012 - 06/2004
5Macular Edema
10/2019 - 04/2013
5Infections
06/2014 - 02/2008
4Neuroinflammatory Diseases
11/2021 - 10/2005
4Human Influenza (Influenza)
12/2019 - 05/2014
4Cognitive Dysfunction
11/2019 - 01/2012
4Chronic Progressive Multiple Sclerosis
01/2019 - 10/2009
3Optic Nerve Diseases (Optic Neuropathy)
11/2021 - 02/2011
3Parkinson Disease (Parkinson's Disease)
01/2021 - 02/2008
3Nervous System Diseases (Neurological Disorders)
01/2018 - 07/2012
3Retrograde Degeneration
06/2017 - 02/2011
3Transverse Myelitis (Necrotizing Myelitis)
05/2008 - 10/2005
2COVID-19
11/2021 - 08/2021
2Headache (Headaches)
01/2019 - 07/2014
2Urinary Tract Infections (Urinary Tract Infection)
01/2019 - 07/2014
2Lymphopenia (Lymphocytopenia)
01/2019 - 06/2014
2Neoplasms (Cancer)
03/2016 - 06/2014
2Edema (Dropsy)
02/2016 - 03/2006
2HIV Infections (HIV Infection)
08/2013 - 02/2006
2Encephalitis (Encephalitis, Rasmussen)
07/2013 - 11/2012
2Glaucoma
06/2012 - 09/2008
1Post-Lyme Disease Syndrome
01/2022
1Tics (Tic)
01/2022
1Autoimmune Diseases of the Nervous System
01/2022
1Adult Form Polyglucosan Body Disease
11/2021
1Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
11/2021
1Cerebrotendinous Xanthomatosis
11/2021
1Stiff-Person Syndrome (Stiff Man Syndrome)
01/2020

Drug/Important Bio-Agent (IBA)

77Retinaldehyde (Retinal)IBA
11/2022 - 02/2006
20Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2006
9Natalizumab (Tysabri)FDA Link
11/2021 - 04/2005
7Monoclonal AntibodiesIBA
10/2022 - 04/2005
7Myelin-Oligodendrocyte GlycoproteinIBA
02/2022 - 06/2012
6Immunoglobulin G (IgG)IBA
01/2022 - 01/2020
6Fingolimod Hydrochloride (FTY720)FDA Link
01/2020 - 11/2012
5Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2006
5Glatiramer Acetate (Copaxone)FDA Link
01/2021 - 04/2002
5Neuroprotective AgentsIBA
01/2021 - 08/2007
5GadoliniumIBA
01/2020 - 08/2008
5MMEIBA
10/2019 - 04/2013
5InterferonsIBA
11/2014 - 04/2002
4Peptides (Polypeptides)IBA
01/2022 - 04/2005
4Rituximab (Mabthera)FDA Link
01/2021 - 10/2009
4CuprizoneIBA
01/2020 - 03/2012
4peginterferon beta-1aIBA
02/2017 - 07/2014
4Cholecalciferol (Vitamin D3)FDA Link
01/2016 - 01/2016
4Interferon-betaIBA
02/2013 - 03/2006
4Interferon beta-1aFDA Link
11/2011 - 03/2006
3AntibodiesIBA
10/2022 - 01/2022
3AntigensIBA
10/2020 - 03/2016
3Dimethyl FumarateIBA
01/2018 - 01/2017
3CytokinesIBA
01/2017 - 06/2005
3Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2013 - 08/2005
2Glycoproteins (Glycoprotein)IBA
11/2021 - 08/2021
2SphingolipidsIBA
01/2021 - 11/2008
2Complement System Proteins (Complement)IBA
01/2021 - 01/2019
2CeramidesIBA
01/2021 - 08/2014
2Matrix Metalloproteinases (MMPs)IBA
01/2019 - 01/2008
2Fatty Acids (Saturated Fatty Acids)IBA
01/2019 - 09/2013
2Alemtuzumab (Campath)FDA Link
01/2018 - 09/2013
2Pharmaceutical PreparationsIBA
01/2018 - 07/2014
2Indicators and Reagents (Reagents)IBA
11/2015 - 03/2012
2Calcitriol (Calcijex)FDA LinkGeneric
02/2015 - 12/2013
2LipidsIBA
08/2014 - 11/2008
2Interleukin-17 (Interleukin 17)IBA
09/2013 - 05/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2013 - 08/2008
2Interleukin-6 (Interleukin 6)IBA
05/2008 - 10/2005
1oligomycin sensitivity-conferring protein (complex V)IBA
11/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
10/2022
1mirfentanilIBA
01/2022
1Protein-Arginine DeiminasesIBA
01/2022
1AutoantibodiesIBA
01/2022
1ProteomeIBA
01/2022
1SteroidsIBA
11/2021
1Complement C3 (C3 Complement)IBA
11/2021
1Aromatic Amino Acids (Aromatic Amino Acid)IBA
10/2021
1ChemokinesIBA
01/2021
1Complement C1q (C1q Complement)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Freund's AdjuvantIBA
01/2021
1Glucagon-Like Peptide-1 ReceptorIBA
01/2021
1Biological ProductsIBA
01/2020
1Bile Acids and Salts (Bile Acids)IBA
01/2020

Therapy/Procedure

29Therapeutics
10/2022 - 06/2004
3Telescopes
07/2015 - 07/2011
3Injections
07/2014 - 02/2008
3Immunomodulation
08/2008 - 04/2005
2Immunotherapy
03/2016 - 09/2013
2Lasers (Laser)
07/2008 - 02/2006
1Precision Medicine
11/2021